Data Integrity in the Age of Metadata and Big Data
![Feat 2 Feat 2](/images/default-source/default-album/pda-letter/new-portal/articles/february-2018/feat-2.jpg?sfvrsn=b87f8e8e_0)
To adapt to the present reality concerning data management, MHRA published GXP Data Integrity Guidance and Definitions, aligned with texts issued by PIC/S, WHO and EMA (1–4). Released in March 2018, the guidance seeks to achieve a reliable relationship between generation of raw information and related decision-making that occurs during drug manufacturing. Metadata will play a key role in achieving this relationship and it takes a prominent place in the guidance.